Hagan Joseph P

CIK 00014652784 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001465278

Recent Transactions

50 trades

Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−990,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−160,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−1,312,500→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−1,350,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock
2025-06-25−571,558→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−6,500→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−249,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−1,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−90,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−100,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−30,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−100,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock Purchase Warrant (Right to Buy)
2025-06-25−2,976→ 0 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2025-01-30+1,350,000→ 1,350,000 total
Purchase
Regulus Therapeutics Inc.
Common Stock
2025-01-30$1.09/sh+50,000→ 260,808 total
Sale
Regulus Therapeutics Inc.
Common Stock
2025-01-14$1.26/sh−11,764→ 210,808 total
Sale
Regulus Therapeutics Inc.
Common Stock
2025-01-13$1.26/sh−115,290→ 222,572 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-01-09$1.36/sh+218,750→ 275,862 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-01-09$1.30/sh+62,000→ 337,862 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-20+990,000→ 990,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2024-01-18$1.19/sh−14,580→ 57,112 total
Award
Regulus Therapeutics Inc.
Common Stock
2024-01-12+30,000→ 71,692 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-01-12+249,000→ 249,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-08-10+1,312,500→ 1,312,500 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2023-05-19$10.58/sh−272→ 11,961 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Restricted Stock Units
2023-05-18−8,733→ 0 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2023-05-18+8,733→ 12,233 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-01-11+100,000→ 100,000 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Restricted Stock Unit
2022-05-18+8,733→ 8,733 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2022-05-18+14,612→ 14,612 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2022-05-10+300,000→ 300,000 total
Purchase
Regulus Therapeutics Inc.
Common Stock
2022-01-26$0.22/sh+100,000→ 417,006 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2022-01-12+1,600,000→ 1,600,000 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-01-03$5.08/sh+40,000→ 43,500 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-01-03$23.29/sh−634→ 3,500 total
Sale
Aurinia Pharmaceuticals Inc.$AUPH
Common Stock
2022-01-03$22.58/sh−39,366→ 4,134 total
Exercise/Conversion
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2022-01-03−40,000→ 10,000 total
Award
Aurinia Pharmaceuticals Inc.$AUPH
Stock Option (right to buy)
2021-06-14+31,347→ 31,347 total
Award
Zosano Pharma Corp
Stock Option (Right to Buy)
2021-06-10+30,000→ 30,000 total
Award
Zosano Pharma Corp
Common Stock
2021-06-10+15,000→ 22,500 total
Sale
Regulus Therapeutics Inc.
Common Stock
2021-05-17$0.89/sh−4,186→ 316,292 total
Conversion
Regulus Therapeutics Inc.
Common Stock
2021-04-14+75,850→ 320,478 total
Conversion
Regulus Therapeutics Inc.
Class A-2 Convertible Preferred Stock
2021-04-14+7,585→ 0 total
Sale
Regulus Therapeutics Inc.
Common Stock
2021-02-16$1.72/sh−4,144→ 485,756 total
Sale
Regulus Therapeutics Inc.
Common Stock
2021-02-16$1.72/sh−4,144→ 244,628 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-04+600,000→ 600,000 total
Award
Regulus Therapeutics Inc.
Common Stock Purchase Warrant (Right to Buy)
2020-12-04$0.13/sh+29,760→ 29,760 total
Award
Regulus Therapeutics Inc.
Common Stock
2020-12-04$0.63/sh+39,680→ 225,674 total
Sale
Regulus Therapeutics Inc.
Common Stock
2020-11-16$0.52/sh−6,094→ 215,994 total
Sale
Regulus Therapeutics Inc.
Common Stock
2020-08-14$0.60/sh−4,245→ 222,088 total

Companies

Recent Filings

Address

C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200

LA JOLLA, CA, 92037

View on SEC.gov